How PCPs can use neuromodulation for migraine treatment

In the U.S., most patients rely on their primary care providers for migraine treatment. These providers often encounter challenges related to medication overuse and systemic side effects—issues that are gaining attention not only in clinical practice but also in broader ethical and public health discussions. That’s why it’s essential for PCPs to familiarize themselves with neuromodulation treatment options for migraine. Neuromodulation’s value lies in its utility as both an acute and preventive treatment, its compatibility as monotherapy or adjunctive therapy, and its favorable safety profile due to the absence of systemic exposure. Read the full guide to neuromodulation for migraine and learn how you can better support your patients with innovative treatment options: https://lnkd.in/epi7bcyn #Neuromodulation #Migraine #PatientEducation #FutureOfHealth

To view or add a comment, sign in

Explore content categories